Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients. Academic Article uri icon

abstract

  • The Clinical Assessment Program and Teflaro Utilization Registry (CAPTURE) is a multicenter study, assessing the contemporary use of ceftaroline fosamil in patients with community-acquired bacterial pneumonia (CABP) or acute bacterial skin and skin structure infection. This article discusses the data collected from 528 evaluable patients with CABP, from 39 sites in the United States, between August 2011 and April 2013. The majority of patients (51%) were elderly (aged 65 years), most of whom were treated in general hospital wards (70%). Approximately one quarter of elderly patients had 2 comorbidities (26%), the most common of which was structural lung disease (51%). The majority of elderly patients received ceftaroline fosamil as second-line therapy (85%), concurrently with other antibiotics (61%). Similar patterns of ceftaroline fosamil usage were noted in younger patients (aged < 65 years). Fifteen patients died (3%), 10 of whom were elderly. The overall clinical success of ceftaroline fosamil was 81% for elderly patients with CABP and 82% for younger patients. These data suggest that ceftaroline fosamil is a potentially effective treatment option for CABP in the elderly.

published proceedings

  • Hosp Pract (1995)

author list (cited authors)

  • Udeani, G., Evans, J., Cole, P., & Friedland, H. D.

citation count

  • 10

complete list of authors

  • Udeani, George||Evans, John||Cole, Phillip||Friedland, H David

publication date

  • August 2014